AM Press ReleasesBioprintingTrends 2024

New report projects bioprinting markets to reach $1.1 bln in 2027

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

A new report, authored by AM market analyst Davide Sher and titled: Bioprinting Markets: Materials, Equipment and Applications, 2017 to 2027, projects that bioprinting will reach $1.1 billion in revenues by 2027.

The report identifies the most commercially important technologies, materials and applications for bioprinting.  It includes ten-year forecasts of bioprinting materials, hardware and applications, along with granular information on current pricing for both bioprinters and printing materials.  The report also provides information on which companies and institutions are using bioprinters today and which printers they are using.  The report was compiled after extensive interviewing of key executives in the industry.

Profiles of leading bioprinting firms including EnvisionTEC, RegenHU, Organovo, Regenovo, Poietis, Cyfuse, CELLINK, Biobots, Rokit, Bioink Solutions, 3D Bioprinting Solutions, Advanced Biomatrix, Aspect Biosystems, Nano3D Biosciences, and Tissue Regeneration Systems. There is also an analysis of the diverse market for “bioinks.” materials, which include polymers, ceramics, cells, cell aggregates, peptides, growth factors, hydrogels, scaffold components, and others.

Although the leading professional bioprinter firms themselves are today often small (see chart below), major multinationals now have bioprinting programs. Such firms include Astellas Pharma, Bristol-Meyers Squibb, Merck, Novartis, Procter and Gamble and Roche. By 2027, SmarTech believes there will be over 5,000 bioprinting systems installed worldwide.

Another driver for bioprinting going forward will be the growing availability of low-cost bioprinters systems. Systems under $20,000 will enable bioprinting to be much more widely used both in industry and in smaller academic institutions.  These will enable the creation of entirely new services in much the same way that low-cost gene-splicing machines have done.

Bioprinting Markets

Although currently a niche sector, bioprinting will take off rapidly in the next few years as today’s trials turn into commercial applications.  SmarTech anticipates a rush to fund bioprinting startups as sales of bioprinters will double between 2016 and 2021.  Firms seeking to establish a foothold in this emerging market are turning up both R&D and market development activity.

While RegenHu and EnvisionTEC currently represent over 50% of the professional bioprinting hardware market, SmarTech sees this situation about to change as more firms enter the space. There is potential for innovative forms to thrive and possibly dislodge either or both, current industry leaders.

Although new bioprinting applications will likely emerge, the majority of bioprinting revenues will come from drug discovery, cosmetics testing, and tissue regeneration.  These three applications will account for more than 90 percent of the revenues in the bioprinting segment over the next decade.

Composites AM 2024

746 composites AM companies individually surveyed and studied. Core composites AM market generated over $785 million in 2023. Market expected to grow to $7.8 billion by 2033 at 25.8% CAGR. This new...


VoxelMatters is the online trade media portal published by 3dpbm, a leading marketing and market research firm specializing in the AM industry. 3dpbm also publishes the 3D Printing Business Directory, the AM Focus eBook series and the 3dpbm Research AM Market Reports. 3D Printing Media Network was founded with the goal to provide the latest industry news, insights and opinions to a global audience of professionals and decision makers.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Technical Cookies
In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services


Join our 12,000+ Professional community and get weekly AM industry insights straight to your inbox. Our editor-curated newsletter equips executives, engineers, and end-users with crucial updates, helping you stay ahead.